Skip to main content
CI
NYSE Life Sciences

Cigna Flags Slowing GLP-1 Drug Trend, Shares Dip 2%

Tom Rudovsky · Reported by Benzinga
More coverage: Financial
Sentiment info
Negative
Importance info
7
Price
$288.42
Mkt Cap
$76.296B
52W Low
$239.51
52W High
$315.47
52W Position info
20% above low
Off High info
8.6% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

CI sits 20% above its 52-week low of $239.51.

Summary

Cigna's CFO disclosed on the Q2 earnings call that GLP-1 drug prescription growth is moderating, with coverage levels slightly declining and utilization growth trending down from prior elevated levels. This trend is expected to persist through year-end and is baked into the raised full-year outlook of at least $30.45 per share. The commentary adds a cautious note to an otherwise strong quarter where revenue and EPS beat consensus. Shares fell about 2%, reflecting concern that a slowdown in high-cost GLP-1 utilization could pressure pharmacy benefit revenue growth at Evernorth. The stock move is modest but the forward-looking signal on a key cost and revenue driver warrants attention.

At the time of this announcement, CI was trading at $288.42 on NYSE in the Life Sciences sector, with a market capitalization of approximately $76.3B. The 52-week trading range was $239.51 to $315.47. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Benzinga.


Price Chart

Share this article

Copied!

CI - Latest Insights

CI
Nov 05, 2026, 1:00 PM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $302.34
Real-time Price: $279.52 info
Change: -$22.82 (-8%) info
Market Cap: $73.782B info
CI
Nov 05, 2026, 11:07 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $312.17
Real-time Price: $279.52 info
Change: -$32.65 (-10%) info
Market Cap: $73.782B info
CI
Nov 05, 2026, 6:51 AM EST
Source: dpa-AFX
Importance Score:
7
Price at Filing: $307.26
Real-time Price: $279.52 info
Change: -$27.74 (-9%) info
Market Cap: $73.782B info
CI
Nov 05, 2026, 6:15 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $307.26
Real-time Price: $279.52 info
Change: -$27.74 (-9%) info
Market Cap: $73.782B info
CI
Nov 05, 2026, 6:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $300.90
Real-time Price: $279.52 info
Change: -$21.38 (-7%) info
Market Cap: $73.782B info